CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in TGTX — Tg Therapeutics, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in TGTX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$43,021,727
+$3,920,278 QoQ
Shares Held
1,295,055
-1.3% QoQ
Ownership
0.846%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TGTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $6,185,699,337 across 288 Biotechnology names. TGTX ranks #31 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,920,871 | $857,745,736 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
804,508 | $621,595,061 | |
| 3 | MRNA |
Moderna, Inc.
|
4,734,356 | $240,505,284 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
673,356 | $222,793,299 | |
| 5 | INSM |
INSMED Inc
|
1,069,390 | $174,866,652 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
1,735,476 | $168,775,041 | |
| 7 | INCY |
Incyte Corp
|
1,729,102 | $162,743,080 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,976,094 | $146,744,740 |
All Filings in TGTX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $43,021,727 | 1,295,055 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $39,101,449 | 1,311,689 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $47,329,421 | 1,310,157 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $47,380,691 | 1,316,496 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $49,797,605 | 1,262,937 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $38,212,341 | 1,269,513 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $27,708,004 | 1,184,609 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $20,932,959 | 1,176,670 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $17,424,104 | 1,145,569 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $19,332,783 | 1,131,896 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $9,302,021 | 1,112,682 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $26,847,320 | 1,080,810 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $15,728,110 | 1,045,752 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $12,046,571 | 1,018,307 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $5,865,879 | 990,858 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $4,002,106 | 941,672 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $9,086,072 | 955,423 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $17,829,486 | 938,394 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $30,433,461 | 914,467 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $33,692,295 | 868,582 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $40,534,416 | 840,963 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $37,827,331 | 727,169 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $18,546,098 | 693,053 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $12,635,857 | 648,658 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $5,431,050 | 551,936 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||